Matinas BioPharma Holdings (MTNB) Capital Expenditures Growth (1y) (2014 - 2023)
Matinas BioPharma Holdings (MTNB) Capital Expenditures Growth (1y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 227.76% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -93.60% |
| Dec 31, 2022 | 17.28% |
| Mar 31, 2020 | -59.64% |
| Sep 30, 2019 | -73.33% |
| Jun 30, 2019 | 100.35% |
| Mar 31, 2019 | -86.02% |
| Sep 30, 2018 | 705.45% |
| Dec 31, 2015 | 2,293,100.00% |
| Sep 30, 2015 | -91.82% |
| Jun 30, 2015 | 141.24% |
| Mar 31, 2015 | -97.49% |
| Dec 31, 2014 | -100.00% |
| Sep 30, 2014 | 526.98% |